Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cosimo Bruni

Showing results (131-140 of 166) with videos related to

Pageof 17
Sort By:
European Journal of Internal Medicine|May 26, 2026
Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR databaseBlaž Burja, Marouane Boubaya, Cosimo Bruni, et al.
RMD Open|November 28, 2024
Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosisRucsandra Dobrota, Alexandru Garaiman, Kim Fligelstone, et al.
Rheumatology (Oxford, England)|June 16, 2022
Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung diseaseCosimo Bruni, Mariaelena Occhipinti, Michael Pienn, et al.
Rheumatology (Oxford, England)|November 26, 2019
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS)Sophie Mavrogeni, Luna Gargani, Alessia Pepe, et al.
RMD Open|February 10, 2025
How to build a framework to establish a patient research partner network in rheumatology research: a report of a 2-year implementation projectKristina Buerki, Melpomeni Toitou, Maarten de Wit, et al.
Rheumatology (Oxford, England)|July 29, 2022
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC modelAlexandru Garaiman, Klaus Steigmiller, Catherine Gebhard, et al.
Annals of the Rheumatic Diseases|November 26, 2021
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaireMike O Becker, Rucsandra Dobrota, Alexandru Garaiman, et al.
Expert Review of Clinical Immunology|June 5, 2026
Measuring disease activity in juvenile systemic sclerosis: a multidisciplinary consensus from the Hamburg 2024 symposiumIvan Foeldvari, Kathryn S Torok, Jens Klotsche, et al.
RMD Open|November 18, 2024
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profileSilvia Bellando-Randone, Edda Russo, Leandro Di Gloria, et al.
Clinical and Experimental Medicine|April 17, 2019
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT studySimone Negrini, Ottavia Magnani, Marco Matucci-Cerinic, et al.
Pageof 17

Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
European Journal of Internal Medicine|May 26, 2026
Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR databaseBlaž Burja, Marouane Boubaya, Cosimo Bruni, et al.
RMD Open|November 28, 2024
Performance of the EULAR Systemic sclerosis Impact of Disease (ScleroID) questionnaire as a patient-reported outcome measure for patients with diffuse systemic sclerosisRucsandra Dobrota, Alexandru Garaiman, Kim Fligelstone, et al.
Rheumatology (Oxford, England)|June 16, 2022
Lung vascular changes as biomarkers of severity in systemic sclerosis-associated interstitial lung diseaseCosimo Bruni, Mariaelena Occhipinti, Michael Pienn, et al.
Rheumatology (Oxford, England)|November 26, 2019
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS)Sophie Mavrogeni, Luna Gargani, Alessia Pepe, et al.
RMD Open|February 10, 2025
How to build a framework to establish a patient research partner network in rheumatology research: a report of a 2-year implementation projectKristina Buerki, Melpomeni Toitou, Maarten de Wit, et al.
Rheumatology (Oxford, England)|July 29, 2022
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC modelAlexandru Garaiman, Klaus Steigmiller, Catherine Gebhard, et al.
Annals of the Rheumatic Diseases|November 26, 2021
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaireMike O Becker, Rucsandra Dobrota, Alexandru Garaiman, et al.
Expert Review of Clinical Immunology|June 5, 2026
Measuring disease activity in juvenile systemic sclerosis: a multidisciplinary consensus from the Hamburg 2024 symposiumIvan Foeldvari, Kathryn S Torok, Jens Klotsche, et al.
RMD Open|November 18, 2024
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profileSilvia Bellando-Randone, Edda Russo, Leandro Di Gloria, et al.
Clinical and Experimental Medicine|April 17, 2019
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT studySimone Negrini, Ottavia Magnani, Marco Matucci-Cerinic, et al.
Pageof 17